Loring Wolcott & Coolidge Fiduciary Advisors LLP Novo Nordisk A S Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.5 Billion
- Q2 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 32,805 shares of NVO stock, worth $3.86 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
32,805
Previous 20,301
61.59%
Holding current value
$3.86 Million
Previous $2.61 Million
79.66%
% of portfolio
0.04%
Previous 0.02%
Shares
24 transactions
Others Institutions Holding NVO
# of Institutions
1,987Shares Held
318MCall Options Held
5.16MPut Options Held
4.97M-
Jennison Associates LLC21.2MShares$2.5 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.72 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.67 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.57 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.48 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $266B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...